中国医药行业上市公司的绩效评价及影响因素———基于面板数据的DEA－Tobit实证研究
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}The Performance Evaluation of Listed Chinese Pharmaceutical Companies and the Influencing Factors: An Empirical DEA － Tobit Evidence Based on the Panel Data
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
